ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB) stock price, news, charts, stock research, profile.
Open | - |
High | - |
52 Wk High | $69.56 |
AUM | 88.71M |
Dividend | $0.46 |
Ex-Div Date | Jun 26, 2024 |
Volume | - |
Market Cap | $53.96B |
Mgmt Fee | 0.75% |
P/E Ratio | 20.22 |
Prev. Close | $55.78 |
Low | - |
52 Wk Low | $47.20 |
Shares Out | 1.63M |
Yield | 0.74% |
Div. Freq | Quarterly |
Avg. Volume Daily | 16.03K |
Beta | 1.40 |
Avg. Expense Ratio | 0.95% |
P/B Ratio | 2.12 |
You can purchase shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) through any online brokerage.
There are no as such competitors for ProShares Ultra Nasdaq Biotechnology.
There is no analysis for ProShares Ultra Nasdaq Biotechnology to provide a consensus price target.
The stock price for ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB) is $55.78 last updated December 17, 2024 at 4:15 PM EST.
A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on September 28, 2010 to stockholders of record on September 21, 2010.
ProShares Ultra Nasdaq Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for ProShares Ultra Nasdaq Biotechnology.
Open | - |
High | - |
52 Wk High | $69.56 |
AUM | 88.71M |
Dividend | $0.46 |
Ex-Div Date | Jun 26, 2024 |
Volume | - |
Market Cap | $53.96B |
Mgmt Fee | 0.75% |
P/E Ratio | 20.22 |
Prev. Close | $55.78 |
Low | - |
52 Wk Low | $47.20 |
Shares Out | 1.63M |
Yield | 0.74% |
Div. Freq | Quarterly |
Avg. Volume Daily | 16.03K |
Beta | 1.40 |
Avg. Expense Ratio | 0.95% |
P/B Ratio | 2.12 |
Sector | Healthcare |
Category | Mid Performer-Mid Growth |
Investment Style | Trading-Leveraged Equity |
Fund Inception | Apr 6, 2010 |
Managers | Tarak Dave Michael Neches |
Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |